Welcome to LookChem.com Sign In|Join Free
  • or
SCH00013, also known as tamoxifen, is a selective estrogen receptor modulator (SERM) that functions as a medication for treating and preventing specific types of breast cancer. It operates by blocking the effects of estrogen in breast tissue, which in turn limits the proliferation of cancer cells. Beyond its anti-cancer applications, SCH00013 has demonstrated potential in the prevention of osteoporosis and as a treatment for infertility.

217963-18-3

Post Buying Request

217963-18-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

217963-18-3 Usage

Uses

Used in Pharmaceutical Industry:
SCH00013 is used as an anti-cancer agent for the treatment and prevention of certain types of breast cancer. It is effective due to its ability to block estrogen receptors, thereby inhibiting the growth of cancer cells.
Used in Orthopedic Applications:
SCH00013 is used as a preventative measure for osteoporosis, potentially reducing the risk of bone fractures and bone loss by modulating the effects of estrogen on bone tissue.
Used in Fertility Treatment:
SCH00013 is used as a treatment for infertility, where it may help improve the chances of conception by influencing hormonal balance and potentially enhancing the conditions for successful fertilization and implantation.

Check Digit Verification of cas no

The CAS Registry Mumber 217963-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,7,9,6 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 217963-18:
(8*2)+(7*1)+(6*7)+(5*9)+(4*6)+(3*3)+(2*1)+(1*8)=153
153 % 10 = 3
So 217963-18-3 is a valid CAS Registry Number.

217963-18-3Upstream product

217963-18-3Downstream Products

217963-18-3Relevant academic research and scientific papers

Heterocyclic compound and cardiotonic agent containing the same as effective component

-

, (2008/06/13)

The present invention relates to a novel heterocyclic compound having excellent positive inotropic effect as cardiotonic agent and suppressing increase of heart rate and a cardiotonic agent containing the novel heterocyclic compound as active component.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 217963-18-3